Business Description

908 Devices Inc. is a technology company that develops and manufactures purpose-built handheld and desktop mass spectrometry devices for chemical and biomolecular analysis. The company's products are used at the point-of-need to detect and identify unknown materials, catering primarily to safety, security, and defense applications such as illicit drug detection and hazardous materials response.

Everything on 908 Devices Inc.

Revenue (FY2025) $56M
YoY growth +17.7%
Operating margin -70.1%
Direction Expanding
Gross margin 50.6%
Net margin -59.2%

Earnings Transcripts

View all transcripts ↗

Leadership & board

View leadership ↗
Kevin J. Knopp, Ph.D. — President, Chief Executive Officer and Director View full profile ↗ Joseph H. Griffith IV — Chief Financial Officer and Treasurer View full profile ↗ Mark S. Levine — Chief Legal and Administrative Officer and Secretary View full profile ↗ Kola Otitoju — Chief Business and Strategy Officer View full profile ↗ John W. Kenneweg — Senior Vice President, Sales and Product Marketing View full profile ↗ Kevin McCallion, Ph.D. — Senior Vice President, Products and Production View full profile ↗ E. Kevin Hrusovsky — Chairman of the Board View full profile ↗ Keith L. Crandell — Director View full profile ↗ Mark Spoto — Director View full profile ↗ Fenel M. Eloi — Director View full profile ↗ Tony J. Hunt — Director View full profile ↗ Michele M. Leonhart — Director View full profile ↗ Christopher Brown, Ph.D. — Director View full profile ↗ Brandi C. Vann, Ph.D. — Director View full profile ↗

Share Repurchase Program

Total authorized
None. 908 Devices does not have a share repurchase or buyback program.
Remaining (Fiscal year ended December 31, 2025)
Not applicable.
Latest FY repurchased
No shares were repurchased under any buyback program; the company has never paid cash dividends and has no repurchase authorization.

Named Competitors

AgilentBrukerDanaherInficonTeledyneRigakuThermo Fisher Scientific

Customer Concentration

No single customer accounted for 10% or more of total revenue for the years ended December 31, 2025 or 2024. As of December 31, 2025, one customer accounted for 34% of gross accounts receivable (20% as of December 31, 2024). Contract revenue was primarily related to one customer (the U.S. government) in both 2025 and 2024, and product placements can fluctuate due to concentrations among larger government customers.

Recent SEC Filings

2026-07-08 Other event View filing ↗
2026-06-12 Shareholder vote results View filing ↗
2026-05-06 Entered a material agreement (+4 more) View filing ↗
2026-03-03 Reported quarterly results View filing ↗
2026-01-20 Reported quarterly results View filing ↗
2025-11-10 Reported quarterly results View filing ↗
2025-08-05 Reported quarterly results View filing ↗
2025-08-04 Leadership change (directors/officers) (+1 more) View filing ↗
2025-06-16 Leadership change (directors/officers) (+1 more) View filing ↗
2025-06-13 Shareholder vote results View filing ↗
2025-05-13 Reported quarterly results View filing ↗
2025-03-04 Reported quarterly results View filing ↗

More Companies

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

You're subscribed.

Thanks for signing up.